# Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

Study · id `cardio:ct-nct02601157` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02601157](<https://clinicaltrials.gov/study/NCT02601157>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02601157

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2173 participants.

## Technical summary

Registry record NCT02601157. Randomized; no masking; primary purpose treatment. Start 2016-01-18 (registry gives no type); primary completion 2021-08-14 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2173 participants (enrolled count; ClinicalTrials.gov record NCT02601157, source copy `cardio:ctgov-nct02601157-2023-01-10`, retrieved 2026-10-31)
- Start date: 2016-01-18 (registry gives no type) (ClinicalTrials.gov record NCT02601157, source copy `cardio:ctgov-nct02601157-2023-01-10`, retrieved 2026-10-31)
- Primary completion: 2021-08-14 (actual) (ClinicalTrials.gov record NCT02601157, source copy `cardio:ctgov-nct02601157-2023-01-10`, retrieved 2026-10-31)
- Completion: 2022-08-14 (actual) (ClinicalTrials.gov record NCT02601157, source copy `cardio:ctgov-nct02601157-2023-01-10`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02601157, source copy `cardio:ctgov-nct02601157-2023-01-10`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02601157-2023-01-10`, retrieved 2026-10-31)

## The registry's words

- Brief title: Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial
- Acronym: HOST-IDEA
- Condition: Stable Angina
- Condition: Unstable Angina
- Condition: Non-ST Segment Elevation Myocardial Infarction
- Intervention (Drug): 3-months DAPT
- Intervention (Drug): 1-year DAPT
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER
- Collaborator: B. Braun Korea Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial (`cardio:pubmed-36871230`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA Trial (`cardio:pubmed-40160090`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 97ebfeeac5de9d438cb3ae42d114f2bb437d02f77b224b2e3580f9c6c68c5c6e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
